The prognostic value of transient ischemic dilatation with otherwise normal SPECT myocardial perfusion imaging: a cautionary note in patients with diabetes and coronary artery disease

J Nucl Cardiol. 2013 Oct;20(5):774-84. doi: 10.1007/s12350-013-9765-4. Epub 2013 Aug 9.

Abstract

Background: The prognostic implications of transient ischemic dilatation (TID) of the left ventricle with otherwise normal single-photon emission computed tomography myocardial perfusion imaging (MPI) remain controversial. Whether this finding may have prognostic implications only in high-risk populations, such as patients with diabetes or manifest coronary artery disease (CAD), is uncertain.

Methods: We conducted a prospective cohort study of 1,236 consecutive patients with normal (99m)Tc-sestamibi MPI, defined as normal perfusion (summed stress score = 0) and normal left ventricle volume and function. TID was defined as >2 standard deviations above the mean of patients with low likelihood of CAD.

Results: The study subjects were followed for 27 ± 9 months. The 76 (6%) patients with TID had a greater rate of cardiac death or myocardial infarction (MI) [4 (5.3%) vs 11 (0.6%), P = .003] independent of covariates [hazard ratio = 6.4, P = .004]. This finding was entirely derived from the subgroup of 294 patients with diabetes or CAD [4 (13.3%) with TID vs 1 (0.4%) without TID, P = .001] independent of covariates. However, TID was not predictive of cardiac death or MI among the 941 patients without diabetes or CAD. Furthermore, TID was not predictive of coronary revascularization.

Conclusions: This study confirms a benign prognosis of TID with otherwise normal MPI in patients without diabetes or CAD, but cautions against extending this conclusion to high-risk individuals, particularly those with diabetes or CAD.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Comorbidity
  • Coronary Artery Disease / complications*
  • Diabetes Complications / diagnosis*
  • Dilatation
  • Disease-Free Survival
  • Humans
  • Middle Aged
  • Myocardial Perfusion Imaging*
  • Myocardial Revascularization
  • Prognosis
  • Proportional Hazards Models
  • Prospective Studies
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Risk Factors
  • Technetium Tc 99m Sestamibi
  • Time Factors
  • Tomography, Emission-Computed, Single-Photon*
  • Treatment Outcome

Substances

  • Radiopharmaceuticals
  • Technetium Tc 99m Sestamibi